Total Payments
$21,211
2024 Payments
$11,304
Companies
43
Transactions
130
Medicare Patients
1,786
Medicare Billing
$240,996
Payment Breakdown by Category
Consulting$18,071 (85.2%)
Food & Beverage$3,081 (14.5%)
Education$58.42 (0.3%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $18,071 | 3 | 85.2% |
| Food and Beverage | $3,081 | 125 | 14.5% |
| Education | $58.42 | 2 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Itamar Medical Inc | $18,290 | 5 | $0 (2024) |
| JAZZ PHARMACEUTICALS INC. | $580.29 | 20 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $218.51 | 11 | $0 (2024) |
| ZOLL Respicardia, Inc. | $165.53 | 1 | $0 (2024) |
| Harmony Biosciences LLC | $164.60 | 6 | $0 (2023) |
| PFIZER INC. | $152.88 | 9 | $0 (2023) |
| Grifols USA, LLC | $142.76 | 7 | $0 (2024) |
| Avadel CNS Pharmaceuticals, LLC | $136.38 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $95.42 | 5 | $0 (2024) |
| Philips North America LLC | $85.21 | 4 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $11,304 | 30 | Itamar Medical Inc ($10,496) |
| 2023 | $7,710 | 38 | Itamar Medical Inc ($6,739) |
| 2022 | $1,413 | 17 | Itamar Medical Inc ($1,055) |
| 2021 | $149.57 | 9 | PFIZER INC. ($53.69) |
| 2020 | $267.53 | 13 | Octapharma USA, Inc. ($79.90) |
| 2019 | $228.21 | 14 | PFIZER INC. ($56.12) |
| 2018 | $105.92 | 7 | Jazz Pharmaceuticals Inc. ($30.47) |
| 2017 | $32.92 | 2 | Sunovion Pharmaceuticals Inc. ($21.87) |
All Payment Transactions
130 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: NEUROLOGY | ||||||
| 12/13/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.01 | General |
| Category: Insomnia | ||||||
| 12/12/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $22.18 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/04/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $18.18 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/29/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $23.61 | General |
| Category: Medical Device | ||||||
| 10/22/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: NEUROLOGY | ||||||
| 10/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $20.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/26/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $22.17 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/25/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $26.00 | General |
| Category: Respiratory | ||||||
| 09/18/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: NEUROLOGY | ||||||
| 08/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 08/21/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $21.43 | General |
| Category: Medical Device | ||||||
| 08/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Immunology | ||||||
| 08/15/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $29.59 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 08/08/2024 | Philips North America LLC | (AK6) Vest Therapy (Device) | Food and Beverage | Cash or cash equivalent | $19.61 | General |
| Category: Medical Device | ||||||
| 07/30/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $29.47 | General |
| Category: Pulmonology | ||||||
| 07/24/2024 | Itamar Medical Inc | WatchPATONE (Device) | Consulting Fee | Cash or cash equivalent | $10,495.77 | General |
| Category: Sleep Apnea testing | ||||||
| 07/24/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: Insomnia | ||||||
| 06/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.78 | General |
| Category: NEUROLOGY | ||||||
| 06/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 06/05/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Insomnia | ||||||
| 05/02/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $30.48 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 05/01/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $27.36 | General |
| Category: NEUROLOGY | ||||||
| 03/14/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Insomnia | ||||||
| 03/05/2024 | ZOLL Respicardia, Inc. | remede System (Device) | Food and Beverage | Cash or cash equivalent | $165.53 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 520 | 632 | $278,198 | $66,700 |
| 2022 | 7 | 503 | 626 | $272,017 | $65,230 |
| 2021 | 10 | 390 | 526 | $259,324 | $60,597 |
| 2020 | 10 | 373 | 491 | $225,505 | $48,468 |
Total Patients
1,786
Total Services
2,275
Medicare Billing
$240,996
Procedure Codes
37
All Medicare Procedures & Services
37 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 176 | 218 | $108,128 | $27,869 | 25.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 81 | 137 | $48,635 | $13,039 | 26.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 50 | 50 | $35,250 | $7,918 | 22.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 24 | 37 | $28,194 | $6,352 | 22.5% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2023 | 98 | 98 | $15,288 | $2,829 | 18.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 20 | 20 | $13,820 | $2,790 | 20.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2023 | 23 | 23 | $10,511 | $2,060 | 19.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2023 | 19 | 20 | $9,480 | $1,896 | 20.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $6,552 | $1,466 | 22.4% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Office | 2023 | 15 | 15 | $2,340 | $481.35 | 20.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 203 | 245 | $121,520 | $31,778 | 26.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 91 | 172 | $61,060 | $14,076 | 23.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 50 | 50 | $35,250 | $7,816 | 22.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 35 | 35 | $24,070 | $5,456 | 22.7% |
| 95800 | Sleep study including heart rate, breathing, and sleep time | Facility | 2022 | 89 | 89 | $13,884 | $2,808 | 20.2% |
| 95810 | Sleep study in sleep lab (6 years or older) | Facility | 2022 | 21 | 21 | $9,597 | $1,995 | 20.8% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Facility | 2022 | 14 | 14 | $6,636 | $1,301 | 19.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 88 | 127 | $62,992 | $17,290 | 27.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 92 | 139 | $49,345 | $11,354 | 23.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 31 | 62 | $47,244 | $10,882 | 23.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 44 | 44 | $31,020 | $7,417 | 23.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 25 | 25 | $17,275 | $3,985 | 23.1% |
| 99292 | Critical care delivery critically ill or injured patient | Facility | 2021 | 22 | 36 | $13,788 | $3,174 | 23.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 22 | 26 | $9,620 | $2,397 | 24.9% |
| 95810 | Sleep monitoring of patient (6 years or older) in sleep lab | Facility | 2021 | 18 | 19 | $8,915 | $1,511 | 17.0% |
About Dr. Matthew Schmitt, M.D
Dr. Matthew Schmitt, M.D is a Pulmonary Disease healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/23/2009. The National Provider Identifier (NPI) number assigned to this provider is 1144558545.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Schmitt, M.D has received a total of $21,211 in payments from pharmaceutical and medical device companies, with $11,304 received in 2024. These payments were reported across 130 transactions from 43 companies. The most common payment nature is "Consulting Fee" ($18,071).
As a Medicare-enrolled provider, Schmitt has provided services to 1,786 Medicare beneficiaries, totaling 2,275 services with total Medicare billing of $240,996. Data is available for 4 years (2020–2023), covering 37 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Atlanta, GA
- Active Since 11/23/2009
- Last Updated 07/21/2022
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1144558545
Products in Payments
- WatchPATONE (Device) $17,235
- WatchPAT (Device) $1,055
- XYWAV (Drug) $467.95
- QUVIVIQ (Drug) $218.51
- remede System (Device) $165.53
- LUMRYZ (Drug) $136.38
- ELIQUIS (Drug) $135.00
- DUPIXENT (Biological) $101.56
- Wakix (Drug) $95.75
- Prolastin-C Liquid (Biological) $88.57
- (AK6) Vest Therapy (Device) $85.21
- INSPIRE (Device) $83.95
- CUTAQUIG (Biological) $79.90
- WAKIX (Drug) $68.85
- Sunosi (Drug) $67.18
- SUNOSI (Drug) $62.18
- UPTRAVI (Drug) $61.69
- TYVASO (Drug) $58.92
- NUCALA (Biological) $51.86
- AirDuo Digihaler (Drug) $49.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Atlanta
Dr. Colin Swenson, M.d, M.D
Pulmonary Disease — Payments: $198,668
Pulmonary Disease $198,668
Gregory Martin, M.d, M.D
Pulmonary Disease — Payments: $98,374
Pulmonary Disease $98,374
Jesse Roman, M.d, M.D
Pulmonary Disease — Payments: $78,820
Pulmonary Disease $78,820
Victor Tseng, M.d, M.D
Pulmonary Disease — Payments: $55,025
Pulmonary Disease $55,025
Dr. Venkatesh Lakshminarayanan, Md, MD
Pulmonary Disease — Payments: $37,215
Pulmonary Disease $37,215
Srihari Veeraraghavan, M.d, M.D
Pulmonary Disease — Payments: $21,153
Pulmonary Disease $21,153